
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp has demonstrated robust organic revenue growth across its segments, particularly with a notable increase of +12.3% year-over-year in 2023. This growth trajectory is further supported by projected steady advancements in the Hospice segment, which is anticipated to achieve revenue growth of +5% to +7%. Additionally, the finalized FY2026 Medicare Hospice rate increase of +2.6%, effective 10/1/25, is expected to enhance financial stability and operational efficiency, contributing positively to the company’s future performance.
Bears say
Addus HomeCare's financial outlook appears negative due to ongoing same-store declines, driven by administrative bottlenecks related to Medicaid redeterminations, leading to higher patient discharges compared to new admissions. The company's reliance on Medicaid funding, which constituted approximately 97% of its segment revenues in 2025 year-to-date, raises concerns about future earnings stability given the uncertainties surrounding the One Big Beautiful Bill Act (OBBBA). Furthermore, despite steady operational execution and a favorable long-term demand backdrop, Addus HomeCare's stock performance has lagged relative to the broader post-acute care sector, indicating a potential disconnect between equity valuation and fundamental performance.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares